Category: Insulet Corp.
Avedro taps ex-Insulet CFO Brian Roberts to be its new finance chief, replacing Rhonda Bracey, who is relocating to the West Coast.
, AtriCure Inc.
, Avedro Inc.
, Given Imaging
, Hologic Inc.
, Insulet Corp.
, Invacare Corp.
, Nextremity Solutions
, OrthoPediatrics Corp.
, Repro-Med Systems Inc.
Here's a look at some of the top Wall Street stories for medical device companies this week: Boston Scientific hits 7-year high; Analysts' 2015 forecast for medtech; Year in review: An IPO a day in 2014; Insulet lowers guidance, shuffles executive deck; Slow return for Philips CT plant takes its toll
Insulet Corp. lowers its 4th-quarter and full-year 2014 guidance and shuffles its executive deck, hiring 6 new executives and showing 1 the door.
There was a significant amount of turnover this year in the corner offices of medical device companies, including exits by some of medtech's biggest names.
There was a revolving door on medtech's corner office this year, with more than 35 CEOs leaving their positions through planned transitions, retirement or termination, according to a MassDevice.com analysis.
Insulet shares gain after the insulin management company turns in solid 3rd-quarter numbers and names a company insider to be its new CFO.
Insulet (NSDQ:PODD) shares are up today after the insulin management company said its 3rd-quarter earnings topped expectations and named a new finance chief.
Longtime Insulet CEO Duane DeSisto is leaving the corner office, to be replaced by former Cytyc chief Patrick Sullivan.
Insulet (NSDQ:PODD) said today that longtime CEO Duane DeSisto is stepping down after a 13-year run at the insulin management company.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Amid political noise, Ishrak seeks to reassure employees on Medtronic-Covidien deal; Will Medtronic follow Walgreen and abandon inversion in Covidien deal?; Medtronic founder Bakken backs Covidien buy; Allergan-Valeant update: SEC launches Ackman probe, Allergan pays up to $588M for Liris bladder drug, Ackman dangles IPO; Allergan CFO Edwards steps down amid hostile Valeant takeover bid
, Biolase Technology Inc.
, Insulet Corp.
, Monarch Medical
, Pershing Square Capital Management
, Trinity Medical
, Valeant Pharmaceuticals
, Volpara Solutions
, Allergan Inc.